Language: English AU
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) (Site 1005)
Western Health-Sunshine & Footscray Hospitals (Site 3023)
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab in Second-line + Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study
The Alfred Hospital-Medical Oncology Alfred Cancer Trials (Site 1004)
Macquarie University-MQ Health Clinical Trials Unit (Site 1259)
Princess Alexandra Hospital (Site 1003)
Westmead Hospital-Department of Medical Oncology (Site 1001)
Icon Cancer Centre Hobart (Site 1465)
A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma
The purpose of this study is to learn if V940 which is an individualized neoantigen therapy (INT; formerly, called messenger ribonucleic acid [mRNA]-4157) with pembrolizumab (MK-3475) is safe and prevents cancer